Ticker Details
Jazz Pharmaceuticals plc Jazz Pharmaceuticals PLC is a biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing differentiated products that address unmet medical needs.
IPO Date:	June 1, 2007
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$12.2B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.43 | 1.97%
Avg Daily Range (30 D):	$2.40 | 1.29%
Avg Daily Range (90 D):	$2.18 | 1.24%

Institutional Daily Volume
Avg Daily Volume:	.59M
Avg Daily Volume (30 D):	.69M
Avg Daily Volume (90 D):	.8M

Trade Size
Avg Trade Size (Sh.):	81
Avg Trade Size (Sh.) (30 D):	49
Avg Trade Size (Sh.) (90 D):	50

Institutional Trades
Total Institutional Trades:	10,607
Avg Institutional Trade:	$4.83M
Avg Institutional Trade (30 D):	$9.2M
Avg Institutional Trade (90 D):	$8.45M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$8.34M
Avg Closing Trade (30 D):	$23.07M
Avg Closing Trade (90 D):	$22.18M
Avg Closing Volume:	63.22K

News

Feb 16, 2026 @ 1:00 PM Artios Strengthens Leadership Team to Accelerate L... Source: Not Specified

Feb 12, 2026 @ 11:00 AM Zymeworks To Report Fourth Quarter and Full Year 2... Source: Na

Jan 27, 2026 @ 5:02 PM Harmony Biosciences' Sales and Profits Have Soared... Source: Dan Caplinger

Jan 27, 2026 @ 11:00 AM Zymeworks Announces Participation in Upcoming Inve... Source: Na

Jan 7, 2026 @ 6:12 PM Jazz Pharmaceuticals' Drug Extends Survival Past T... Source: Vandana Singh

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-6.05	$4.14	$-11.74
Diluted EPS	$-6.16	$4.08	$-11.74
Revenue	$4.16B	$1.13B	$1.05B
Gross Profit
Net Income / Loss	$-368.48M	$251.41M	$-718.47M
Operating Income / Loss	$-494.01M	$57.51M	$-686.39M
Cost of Revenue
Net Cash Flow	$-892.07M	$136.19M	$-672.07M
PE Ratio